European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
January 09, 2023 at 06:58 AM EST
European drugmakers announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |